Transcriptomics

Dataset Information

0

Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasms (MPN)


ABSTRACT: Even though mutations in epigenetic regulators frequently occur in myeloproliferative neoplasms, their effects on the epigenome have not been well studied. Furthermore, even though primary myelofibrosis (PMF) has a markedly worse prognosis compared to essential thrombocytosis (ET) or polycythemia vera (PV), the molecular distinctions between these subgroups are not well elucidated. We performed the HELP (HpaII tiny fragment enriched by LM-PCR) assay to study genome-wide methylation in PV, ET and PMF samples compared with healthy controls. We determined that PV and ET are characterized by aberrant promoter hypermethylation while PMF is an epigenetically distinct subgroup characterized by both aberrant hyper and hypomethylation. Aberrant hypomethylation in PMF was seen to occur in non CpG island loci, demonstrating further qualitative differences between the disease subgroups. The differentially methylated genes in PV and ET were involved predominantly in cell signaling pathways and were enriched for binding sites of GATA1 and other transcription factors. In contrast, aberrantly methylated genes in PMF were involved in inflammatory pathways and were enriched for NF1 (NFI), LEF1 and other transcription factors. Within the PMF subgroup, cases with ASXL1 disruptions formed an epigenetically distinct subgroup with relatively increased methylation. Cases of MPNs with TET2 mutations demonstrated decreased levels of hydroxymethylation and distinct set of hypermethylated genes. In contrast, the JAK2V617F mutation did not drive epigenetic clustering within MPNs. Finally, the significance of aberrant methylation was demonstrated by sensitivity of MPN derived cell lines to decitabine. These results demonstrate epigenetic differences between PMF and PV/ET and reveal methylomic signatures of ASXL1 and TET2 mutations. The study population consisted of 26 MPN patients (6 cases of ET, 8 cases of PV and 12 cases of PMF) and 3 healthy controls. Individual HpaII restriction digest profiles were compared to an internal MspI digest control, to yield differentially methylated fragments for every sample. The purpose of this study was to assess genome wide patterns of DNA methylation across the MPN stratified by disease class.

ORGANISM(S): Homo sapiens  

SUBMITTER: S Nischal   A Verma  Yiting Yu 

PROVIDER: E-GEOD-42721 | ArrayExpress | 2012-12-05

SECONDARY ACCESSION(S): GSE42721PRJNA182945

REPOSITORIES: GEO, ArrayExpress

Similar Datasets

| GSE42721 | GEO
| GSE120362 | GEO
| GSE55976 | GEO
2013-06-27 | E-GEOD-38295 | ArrayExpress
2015-03-31 | E-GEOD-38543 | ArrayExpress
2013-06-27 | E-GEOD-44860 | ArrayExpress
2008-04-01 | E-GEOD-10894 | ArrayExpress
2015-05-20 | E-GEOD-60233 | ArrayExpress
2010-05-07 | E-GEOD-14417 | ArrayExpress
2010-05-15 | E-GEOD-17328 | ArrayExpress